Monoclonal gammopathy of undetermined significance screening: Difference between revisions
Created page with "__NOTOC__ {{ Monoclonal gammopathy of undetermined significance }} Please help WikiDoc by adding content here. It's easy! Click here to learn a..." |
|||
| Line 1: | Line 1: | ||
== Overview == | |||
__NOTOC__ | __NOTOC__ | ||
{{ Monoclonal gammopathy of undetermined significance }} | {{Monoclonal gammopathy of undetermined significance }} | ||
There is no role of screening in patients for [[monoclonal gammopathy of undetermined significance]]<ref name="pmid20507313">{{cite journal |vauthors=Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA |title=Monoclonal gammopathy of undetermined significance: a consensus statement |journal=Br. J. Haematol. |volume=150 |issue=1 |pages=28–38 |date=July 2010 |pmid=20507313 |doi=10.1111/j.1365-2141.2010.08207.x |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 14:41, 8 August 2018
Overview
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance screening On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance screening |
|
FDA on Monoclonal gammopathy of undetermined significance screening |
|
on Monoclonal gammopathy of undetermined significance screening |
|
Monoclonal gammopathy of undetermined significance screening in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance screening |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
|
Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance screening |
There is no role of screening in patients for monoclonal gammopathy of undetermined significance[1]
References
- ↑ Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (July 2010). "Monoclonal gammopathy of undetermined significance: a consensus statement". Br. J. Haematol. 150 (1): 28–38. doi:10.1111/j.1365-2141.2010.08207.x. PMID 20507313.